Five patients with exacerbation of chronic bronchitis received as a single iv injection 500 mg of ampicillin and 500 mg of amoxycillin. Blood and sputum samples were collected at timed intervals following dosing and the concentrations of the two antibiotics present in the samples were determined by HPLC analysis. No statistically significant differences were observed between the serum concentrations of ampicillin and amoxycillin, and the pharmacokinetics of the two drugs were almost identical, with half lives of 93 min (amoxycillin) and 103 min (ampicillin). Sputum amoxycillin concentrations were significantly higher (Student's paired t-test; P < 0-001) than those of ampicillin, with mean levels two hours after dosing of 2-9 mg/1 (range 1-9-4O) for amoxycillin and 1-4 mg/1 (range 0-8-2-4) for ampicillin. 0305-7453/90/030385+08 $0200/0
Introduction
For the past two decades ampicillin and, more recently, amoxycillin have been used extensively in the treatment of respiratory tract infections. Although there would appear to be little difference in clinical efficacy when the two drugs are given in dosages achieving similar serum levels (MacKay, 1980) , a number of workers have reported higher sputum levels with amoxycillin than with ampicillin (Stewart et al., 1974; Bergogne-Berezin et a/., 1978) . In the studies that report higher amoxycillin levels a cross-over design was not employed and different patients received different antibiotics. Since other workers have found the sputum levels of both amoxycillin and ampicillin to vary considerably from patient to patient, and also within the same patient depending on sputum punilence (May & Ingold, 1972; Sahn, Baird & Sahn, 1978; Law et al, 1983) , the significance of the reported higher amoxycillin concentrations remains unproven.
Antibiotic penetration into homogeneous matrices, such as blister fluid and even bronchial mucosa, is a fairly reproducible process which may be defined by kinetic modelling (Wise, 1986; Mattie et al^ 1987) . In contrast, with non-homogeneous matrices, such as urine, faeces, bone and sputum, the derivation of such kinetic models is difficult, if not impossible, since the observed antibiotic levels are not simply related to plasma levels, but are profoundly influenced by other factors, such as diuresis in the case of urine or punilence in the case of sputum. Owing to the influence of these various factors, the antibiotic levels found in such samples vary greatly, both between patients and also within the same patient depending upon sample. This makes comparative 385 studies of the penetration of two antibiotics difficult, since large numbers of volunteers need to be recruited into such studies to determine whether any observed differences are significant In this paper we present a novel approach to this problem, whereby both drugs are given simultaneously to the same patient and then assayed independently of each other. This approach permits a direct comparison of the levels of the two drugs observed in the samples, independent of any variability due, as in the case of this study, to sputum purulence, saliva contamination or inaccurate timings. Furthermore, since paired data are collected the statistical significance of any findings can be tested with considerably fewer subjects than would be required with a conventional two-group design. Using this novel approach we report the serum pharmocokinetics of both ampicillin and amoxycillin, and also their penetration into sputum, following the simultaneous iv administration of 500 mg of each to patients with exacerbations of chronic bronchitis.
Materials and methods

Study protocol
This was approved by the local institutional review committee, and all subjects gave written consent Five hospital inpatients with exacerbation of chronic bronchitis participated in the study. All were current or ex-smokers who expectorated sputum on a regular basis. They were all admitted to hospital with dyspnoea and a change in sputum colour or volume suggestive of an infection. None of the patients had received antimicrobial chemotherapy during the 72 h prior to the study. After an overnight fast, an indwelling cannula was introduced into a forearm vein and a rapid intravenous injection of amoxycillin (500 mg) and ampicillin (500 mg) was administered into the contralateral arm. The two antibiotics were each dissolved in 5 ml of sterile water and drawn into separate syringes, and were then administered sequentially through the same needle with the order of administration randomised between patients. At timed intervals 8 ml blood samples were drawn from the indwelling catheter, which was kept patent by flushing with heparinised saline, and were left to clot These samples were then centrifuged (2000 g for 5 min) and the serum was stored at -70 c C. At timed intervals samples of sputum were collected by unprovoked expectoration and also stored at -70°C.
Laboratory procedures
Samples were assayed for the presence of amoxycillin and ampicillin by high performance liquid chromatography. Chromatography was performed using a Model 6000A pump, a Model 441 detector (Waters Associates, Harrow, UKX a Gilson Model 231 autoinjector cooled at 4°C (Anachem Ltd, Luton, UK), a computing integrator (Trivector Scientific Ltd, Sandy, UKX and a 150x4 mm Hypersil 5 ODS column (HPLC Technology, Macclesfield, UK). The mobile phase was pumped at a flow of 2ml/min and was composed of: (a) for the assay of amoxycillin; methanol: water: H 3 PO 4 (25:74:1) plus 1 g/1 of heptane sulphonic acid and with the pH adjusted to 4-5 or (b) for the assay of ampicillin; methanol: water: H 3 PO 4 (30:69:1) plus 1 g/1 of heptane sulphonic acid and with the pH adjusted to 5-0. Detection was by UV absorbance at 214 run.
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prior to assay. Serum samples were diluted with an equal volume of ice-cold perchloric acid (3-3%), stored at 4°C for 5 min while protein precipitation occurred, then centrifuged at 5000 g for 5 min. A 50-/J volume of the resultant supernatant was then injected immediately into the chromatograph. Sputum samples were liquefied by a 10 sec burst from an ultra sonicator (Dawe Instruments, London, UK) and then treated in an identical manner to serum samples except that a 150 /J volume of the supernatant was injected into the chromatograph. Earlier experiments with sputum samples spiked with known concentrations of amoxycillin and ampicillin showed recovery of both drugs to be similar and approximately 100% Quantitation of amoxycillin or ampicillin was by comparison of peak heights with external standards. Using these procedures the coefficient of variation of intra-assay precision was within the range 3%-6% (n = 6). Determination of pharmacokinetic parameters for individual volunteers was done with a commercial software package (Siphar, Simed SA, Cedex, France) operating on a Nee Power Mate 2 personal computer (NEC Computers, London, UK). The serum concentrations of both drugs were fitted to a two compartment model by either the extended or the least squares method, minimising the sum of the squared differences between experimental and computed values, using the error variance associated with each measure as a weighting factor. Pharmacokinetic plots were visually inspected and the error model giving the best fit line (as determined by visual examination and comparison of residuals) was chosen.
Results
Serum samples
The serum concentrations of both amoxycillin and ampicillin at timed intervals following their administration to the individual volunteers are shown in Table I while the mean values are shown in Figure 1 . Although the serum concentration profiles of the two antibiotics were almost identical, with volunteer 1 the peak amoxycillin level was observed at 10 min while that of ampicillin was observed at 20 min. With this volunteer the ampicillin dose was given after the amoxycillin dose and a slight delay of a few minutes occurred between their administration. Pharmacokinetic modelling of the serum levels of both drugs indicates that they are best described by a two compartment model for which the derived parameters are summarised in Table II. No statistical differences (Student's paired t-test; P > 0-05) were observed between the half-lives, volumes of distribution, areas under the curve, or peak concentrations obtained with either amoxycillin or ampicillin.
Sputum samples
The sputum amoxycillin and ampicillin concentrations found in the five volunteers are shown in Table m , with mean levels shown in Figure 1 . The majority of the sputum samples obtained were purulent, as judged by physical appearance, and the levels of the antibiotics found ranged from 07 to 40 mg/1 for amoxycillin and 0-4 to 2-6 mg/1 for ampicillin. For both drugs peak levels occurred at between 2 and 4 h after dosing, with the peak amoxycillin concentration of 3-2 mg/1 (95% CL 2-0-4-4 mg/1) observed at 4 h post dose and the peak ampicillin concentration of 1-4 mg/1 (95% CL 01-2-5 mg/1) at 2 h post dose. Detectable levels of both drugs were present in the sputum of two of the (Table ITI) . For all bar one of the sputum samples the amoxycillin levels were higher than the ampicillin ones. This was statistically significant (Student's paired t-test; P < O001), with the mean amoxycillin level of 25 mg/1 (95% confidence limits (CL) 05-4-5 mg/1) almost twice that of the ampicillin level at 1-3 mg/1 (95% CL 01-2-5 mg/1).
With two of the volunteers (nos. 2 and 4) it was possible to detect both antibiotics in the sputum samples collected at the time of dosing (time zero, Table II ). Since it was not always possible for the patients to produce sputum samples to the exact timings requested, it is probable that the samples were collected shortly after the administration of the antibiotics.
Discussion
Following the simultaneous administration of ampicillin and amoxycillin (500 mg of each) to the five patients in this study the serum levels of the two antibiotics were almost identical (Figure 1 ) and the phannacokinetics of the two drugs were similar (Table II) . The mean half-lives determined, 93 min for amoxycillin and 103 min for ampicillin, although similar to the reported values of around 72 min for amoxyciUin and 78 min for ampicillin (Philipson, Sabath & Rosner, 1975; Spyer et al., 1977) , were slightly increased The mean age of the patients in this study (66 years; range 57-72) is greater than that of the volunteers reported in the other studies and we would postulate that the slightly increased half-lives result from a lower renal efficiency in this patient group. The effect of renal insufficiency on the half-lives of /Mactam antibiotics is well documented (Humbert et al, 1979) .
The mean sputum concentrations observed in this study were 2-5 mg/1 (95% CL 0-5-4-5 mg/1) for amoxyciUin and 1-3 mg/1 (95% CL 0-1-2-5 mg/1) for ampiciUin. These levels are consistent with the sputum levels reported by other workers, where amoxy-ciUin levels up to 3 mg/1 were obtained following a 500 mg oral dose and levels of 1-8 mg/1 were found 1 h after a 1000 mg iv dose; and where ampiciUin levels of up to 4 mg/1 were obtained following a 1000 mg/1 oral dose (Wong et aU 1975; Sahn et a\ n 1978; Law et al^ 1983; Gould Legge & Reid, 1988) . In the reported studies, and also in this study, considerable variation was observed in the sputum concentrations of the two drugs, both between patients and also within the same patient However, owing to the design of this study, whereby both drugs were administered simultaneously by iv injection and then assayed in the same samples, a number of the variables present in earlier studies have been eliminated. By administering both antibiotics as simultaneous iv injections almost identical plasma concentrations were obtained (Figure 1) , ensuring that any differences in penetration were not due to differences in plasma concentration, as are observed following oral administration. Assaying both drugs in the same sputum samples eliminated any variability due to inaccurate sample timings, dilution by saliva or difference in purulence, as these factors would equally affect both drugs. Consequently it was possible to make a direct comparison between the sputum amoxyciUin and ampiciUin concentrations.
For all bar one of the sputum samples the amoxyciUin concentrations were significantly higher (Students paired {-test; P < 0-001) than the ampiciUin ones, with a mean amoxyciUin concentration of 2-5 mg/L almost twice the ampiciUin concentration of 1-3 mg/1. These data confirm the claims made by earlier workers that amoxyciUin achieves better sputum penetration than ampicillin. The clinical relevance of this remains, however, unclear as there would appear to be little, if any, difference in the clinical efficacy of the two agents when used in the treatment of respiratory tract infection (MacKay, 1980) . While the simultaneous administration of two related antibiotics to permit a direct comparison of their pharmacokinetics had been reported previously (Polk, Kline & Markowitz, 1981) , as far as we are aware this is the first time the technique has been reported for the evaluation of the penetration of two antibiotics into sputum. The major advantages of this approach are that any inter-subject variability is eliminated and each subject provides paired data points, thus reducing both the errors associated with a conventional two-group study design and also the number of subjects required. However, in studies of this kind the assumption is made that the pharmacokinetics of the individual drugs are unaffected by their simultaneous administration. For /Mactams this assumption would appear true (Polk et al., 1981) , especiaUy considering the number of years that combinations of /3-lactams have been used clinicaUy without reports of alteration in their serum pharmacokinetics relative to the individual compounds. However, Lode et al. (1983) have reported a slight, although non-significant, alteration in the pharmacokinetics of latamoxef when given concurrently with azlociUin and Okura, Haruta & Kobayaskhi (1988) have reported a reduced CSF penetration in rabbits of amoxycillin when given with ceftazidime, although its serum pharmacokinetics were unaffected. It is unlikely, though, that co-administration of amoxycillin and ampicillin alters their pharmacokinetics since both exhibit dose independent pharmacokinetics (Spyer et al^ 1977; Humbert et al^ 1979) .
In conclusion, by the simultaneous iv administration of amoxycillin and ampicillin to just five patients with exacerbations of chronic bronchitis, by the use of this novel study design, we have been able to confirm that amoxycillin achieves better sputum penetration than ampicillin.
